ArticleBMC cancer2018

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study.

Cheng-Maw Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.